Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Humira in Japanese subjects with moderately to severely active ulcerative colitis
NCT00853099Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Feb 2009
- Primary completion
- May 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of adalimumab in ulcerative colitis (UC), sponsored by AbbVie Inc.. Started Feb 2009; status: completed.
02
Drugs
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00853099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00853099.